OXOS Medical announced FDA clearance expanding its MC2 portable X-ray system to pediatric imaging, letting clinicians perform low-dose X-rays in the same room as a child's caregiver instead of a separate exam room. The update adds pediatric-specific dose-control features, including an automatic collimator, manual collimation pucks and a pediatric filter, building on MC2's original FDA 510(k) clearance. OXOS Medical is a Parkway Venture Capital portfolio company.
Read the full article: OXOS Medical's announcement of MC2's pediatric clearance
Share
Greatness lies ahead
Sign up for updates from the cutting edge of deep tech venture capital.
You’re on the list!
Something went wrong while submitting the form.
